ChiCTR2100050024
Untitled Trial
A randomized, double blind, placebo controlled phase I clinical trial to evaluate the safety and immunogenicity of the Novel Coronavirus inactivated vaccine (Vero cells) in healthy individuals 18 years of age and older
Hunan Provincial Center for Disease Control and Prevention·Phase 1·Chinese Clinical Trial RegistryNot yet recruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- Hunan Provincial Center for Disease Control and Prevention
- Funder
- Ningbo Rong an Biological pharmaceutical Co., LTD
- Location
- China
Timeline & enrollment
- Phase
- Phase 1
- Start date
- N/A
- End date
- Apr 30, 2023
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100050024
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100050024 through Pure Global AI's free database. This Phase 1 trial is sponsored by Hunan Provincial Center for Disease Control and Prevention and is currently Not yet recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.